치료용 침대 시장 보고서 : 제품, 용도, 최종사용자, 지역별(2025-2033년)

The global therapeutic beds market size reached USD 4.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.8 Billion by 2033, exhibiting a growth rate (CAGR) of 4.02% during 2025-2033. The rising elderly population requires better comfort and care in hospitals and homes, which is augmenting the market.

Clinical therapeutic beds are specially designed beds that provide maximum patient comfort and improve healthcare delivery. These beds are intended to be used in controlled clinical environments, such as nursing homes, diagnostic laboratories, and outpatient clinics. Additional positioning aids, such as pads, pillows, and wedges, are also included with these adjustable beds. When compared to regular beds, these beds and mattresses are designed to lower acupoints, regulate body temperature, prevent bedsores, and improve blood flow. In addition to this, they are equipped with advanced features, such as electronic elevation, side rails, and wheels, thereby providing portability and safety for patients. In the event of surgery, injury, or degenerative disease, therapy beds fulfill the comfort and positioning needs associated with the medical condition.

Therapeutic Beds Market Trends:

The global market is majorly driven by continual technological advancements in the healthcare sector. This can be attributed to the extensive research and development (R&D) activities conducted by the key players focusing on introducing innovative product variants. In addition to this, a considerable rise in consumer awareness regarding health and wellness is acting as a significant growth-inducing factor for the market. The market is further propelled by the rising geriatric population susceptible to developing several chronic illnesses and requiring longer hospital stays. In line with this, the expanding medical expenditure and growing funding by public and private agencies to improve the overall healthcare infrastructure are acting as other major growth-inducing factors. Some of the other factors contributing to the market include the escalating demand for preoperative and postoperative critical care services, the rising prevalence of lifestyle-related diseases, growing expenditure on patient care, and increasing investments for improving the number of beds to patient ratio.

Key Market Segmentation:

Breakup by Product:

• Clinical Beds
• Regular Beds
• ICU Beds
• Pediatric Beds
• Birthing Beds
• Bariatric Beds
• Low Air Loss Beds
• Others
• Household Beds
• Accessories

Breakup by Application:

• Acute Care Beds
• Critical Care Beds
• Long-term Beds

Breakup by End User:

• Hospital and Clinics
• Reproductive Care Centers
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amico Group of Companies, Arjo AB, Centrobed Ltd., GF Health Products Inc., HARD Manufacturing Company Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), Invacare Corporation, Medical Depot Inc. (DBA Drive DeVilbiss Healthcare), Medline Industries LP and Stryker Corporation.

Key Questions Answered in This Report

• 1.What was the size of the global therapeutic beds market in 2024?
• 2.What is the expected growth rate of the global therapeutic beds market during 2025-2033?
• 3.What are the key factors driving the global therapeutic beds market?
• 4.What has been the impact of COVID-19 on the global therapeutic beds market growth?
• 5.What is the breakup of the global therapeutic beds market based on the product?
• 6.What is the breakup of the global therapeutic beds market based on the application?
• 7.What is the breakup of the global therapeutic beds market based on end user?
• 8.What are the key regions in the global therapeutic beds market?
• 9.Who are the key players/companies in the global therapeutic beds market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Therapeutic Beds Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Clinical Beds
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Regular Beds
    • 6.1.2.2 ICU Beds
    • 6.1.2.3 Pediatric Beds
    • 6.1.2.4 Birthing Beds
    • 6.1.2.5 Bariatric Beds
    • 6.1.2.6 Low Air Loss Beds
    • 6.1.2.7 Others
  • 6.1.3 Market Forecast
• 6.2 Household Beds
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Accessories
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Application

• 7.1 Acute Care Beds
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Critical Care Beds
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Long-term Beds
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospital and Clinics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Reproductive Care Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Amico Group of Companies
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Arjo AB
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
  • 14.3.3 Centrobed Ltd.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 GF Health Products Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 HARD Manufacturing Company Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Hill-Rom Holdings Inc. (Baxter International Inc.)
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 SWOT Analysis
  • 14.3.7 Invacare Corporation
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Medical Depot Inc. (DBA Drive DeVilbiss Healthcare)
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Medline Industries LP
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 SWOT Analysis
  • 14.3.10 Stryker Corporation
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis